Complications of Intravascular Catheters in ICU: Definitions, Incidence and Severity. A Randomized Controlled Trial Comparing Usual Transparent Dressings Versus New-generation Dressings (the ADVANCED Study)

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2016 Oct 14

PMID 27734108

Citations 20

Authors

Silvia Calvino Gunther

Carole Schwebel

Rebecca Hamidfar-Roy

Agnes Bonadona

Maxime Lugosi

Claire Ara-Somohano

Clemence Minet

Leila Potton

Jean-Charles Cartier

Aurelien Vesin

Magalie Chautemps

Lenka Styfalova

Stephane Ruckly

Jean-Francois Timsit

Affiliations

Soon will be listed here.

Abstract

Purpose: To describe all post-insertion complications involving most used intravascular access, and to determine whether the use of a new-generation transparent dressing (3M™ IV Advanced) might reduce their number and impact on ICU patient outcomes.

Methods: Patients older than 18, with an expected length of stay ≥48 h and requiring at least one central venous catheter (CVC), arterial catheter (AC), haemodialysis catheter (HDC), pulmonary arterial catheters (PAC) or peripheral venous catheter (PVC) were randomized into two groups: a new-generation transparent dressing, or the hospital's classical transparent dressing, and were followed daily for any infectious and non-infectious complications. Complications were graduated for severity by an independent international multicentre multidisciplinary panel of practitioners using a Delphi process.

Results: We included 628 patients, 2214 catheters (873 PVCs, 630 CVCs, 512 ACs and 199 HDCs and PACs) and 4836 dressings. Overall incidence rate was of 60.9/1000 catheter-days. The most common complication was dysfunction (34.6/1000 catheter-days), mainly for PVCs (16/1000 catheter-days) and ACs (12.9/1000 catheter-days). Infectious complications incidence rate in CVCs and ACs was of 14.5/1000, mostly due to colonization (14.2/1000 catheter-days). Thrombosis incidence was of 3.8/1000 catheter-days with severe and very severe complications in 16 cases (1.8/1000 catheter-days) and one thrombosis-related death. 3M™ IV Advanced dressing did not decrease the rate of catheters with at least a minor complication [57.37/1000 vs. 57.52/1000 catheter-days, HR 1.03, CI (0.84-1.27), p = 0.81]. Incidence rates for each single complication remained equivalent: infectious [HR 0.93 (0.62-1.40), p = 0.72], deep thrombosis [HR 0.90 (0.39-2.06), p = 0.80], extravasation and phlebitis [HR 1.40 (0.69-2.82), p = 0.35], accidental removal [1.07 (0.56-2.04), p = 0.84] and dysfunction [HR 1.04 (0.80-1.35), p = 0.79].

Conclusion: The ADVANCED study showed the overall risk of complications to intravascular catheters in ICU patients being dysfunction, infection and thrombosis. The 3M™ IV Advanced dressing did not decrease complication rates as compared to standard dressings.

Citing Articles

Prediction of the ideal length of insertion to monitor left atrial pressures in pediatric open-heart surgery: a retrospective cohort study.

Zhang Y, Chen X, Wu Z, Li H, Dai R, Zhang S BMC Cardiovasc Disord. 2025; 25(1):178.

PMID: 40082803 PMC: 11905710. DOI: 10.1186/s12872-025-04616-9.

Securing Jugular Central Venous Catheters With Dressings Fixed to a Liquid Adhesive to Prevent Dressing Failure in Intensive Care Patients (the STICKY Trial): A Randomized Controlled Trial.

Marsh N, OBrien C, Larsen E, Alexandrou E, Ware R, Pearse I Crit Care Med. 2025; 53(2):e282-e293.

PMID: 39982180 PMC: 11801464. DOI: 10.1097/CCM.0000000000006533.

Development of a Machine Learning-Based Model for Predicting the Incidence of Peripheral Intravenous Catheter-Associated Phlebitis.

Yasuda H, Rickard C, Mimoz O, Marsh N, Schults J, Drugeon B J Crit Care Med (Targu Mures). 2024; 10(3):232-244.

PMID: 39108413 PMC: 11295139. DOI: 10.2478/jccm-2024-0028.

Dressings and securement devices to prevent complications for peripheral arterial catheters.

Schults J, Reynolds H, Rickard C, Culwick M, Mihala G, Alexandrou E Cochrane Database Syst Rev. 2024; 5():CD013023.

PMID: 38780138 PMC: 11112983. DOI: 10.1002/14651858.CD013023.pub2.

Incidence of asymptomatic catheter-related thrombosis in intensive care unit patients: a prospective cohort study.

Abbruzzese C, Guzzardella A, Consonni D, Turconi G, Bonetti C, Brioni M Ann Intensive Care. 2023; 13(1):106.

PMID: 37858003 PMC: 10587047. DOI: 10.1186/s13613-023-01206-w.

References

Timsit J, LHeriteau F, Lepape A, Francais A, Ruckly S, Venier A . A multicentre analysis of catheter-related infection based on a hierarchical model. Intensive Care Med. 2012; 38(10):1662-72. DOI: 10.1007/s00134-012-2645-6. View

Mermel L . Prevention of central venous catheter-related infections: what works other than impregnated or coated catheters?. J Hosp Infect. 2007; 65 Suppl 2:30-3. DOI: 10.1016/S0195-6701(07)60011-5. View

Timsit J, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S . Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012; 186(12):1272-8. DOI: 10.1164/rccm.201206-1038OC. View

Gonzalez Lopez J, Arribi Vilela A, Fernandez del Palacio E, Olivares Corral J, Benedicto Marti C, Herrera Portal P . Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2013; 86(2):117-26. DOI: 10.1016/j.jhin.2013.10.008. View

Bouza E, Guembe M, Munoz P . Selection of the vascular catheter: can it minimise the risk of infection?. Int J Antimicrob Agents. 2010; 36 Suppl 2:S22-5. DOI: 10.1016/j.ijantimicag.2010.11.002. View

Timsit J, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S . Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009; 301(12):1231-41. DOI: 10.1001/jama.2009.376. View

Webster J, Gillies D, ORiordan E, Sherriff K, Rickard C . Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev. 2011; (11):CD003827. DOI: 10.1002/14651858.CD003827.pub2. View

Ricard J, Salomon L, Boyer A, Thiery G, Meybeck A, Roy C . Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med. 2013; 41(9):2108-15. DOI: 10.1097/CCM.0b013e31828a42c5. View

Renaud B, Brun-Buisson C . Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 2001; 163(7):1584-90. DOI: 10.1164/ajrccm.163.7.9912080. View

10.

Wilson P, Lertdumrongluk P, Leray-Moragues H, Chenine-Koualef L, Patrier L, Canaud B . Prevention and management of dialysis catheter complications in the intensive care unit. Blood Purif. 2012; 34(2):194-9. DOI: 10.1159/000341721. View

11.

Marsh N, Webster J, Mihala G, Rickard C . Devices and dressings to secure peripheral venous catheters to prevent complications. Cochrane Database Syst Rev. 2015; (6):CD011070. PMC: 10686038. DOI: 10.1002/14651858.CD011070.pub2. View

12.

Pittet D, Tarara D, Wenzel R . Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994; 271(20):1598-601. DOI: 10.1001/jama.271.20.1598. View

13.

Baskin J, Pui C, Reiss U, Wilimas J, Metzger M, Ribeiro R . Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet. 2009; 374(9684):159-69. PMC: 2814365. DOI: 10.1016/S0140-6736(09)60220-8. View

14.

Ullman A, Cooke M, Mitchell M, Lin F, New K, Long D . Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review. Int J Nurs Stud. 2016; 59:177-96. DOI: 10.1016/j.ijnurstu.2016.04.003. View

15.

Rutledge L, DeCabooter D, Walters S, Bernatchez S . Catheter securement systems: comparison of two investigational devices to a sutureless securement device, a securement dressing, and sutures in a pig model. Intensive Care Med Exp. 2015; 3(1):60. PMC: 4549365. DOI: 10.1186/s40635-015-0060-3. View

16.

Mimoz O, Lucet J, Kerforne T, Pascal J, Souweine B, Goudet V . Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial.... Lancet. 2015; 386(10008):2069-2077. DOI: 10.1016/S0140-6736(15)00244-5. View

17.

Timsit J, Farkas J, Boyer J, Martin J, Misset B, Renaud B . Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest. 1998; 114(1):207-13. DOI: 10.1378/chest.114.1.207. View

18.

Betjes M . Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat Rev Nephrol. 2011; 7(5):257-65. DOI: 10.1038/nrneph.2011.28. View

19.

Maki D, Kluger D, Crnich C . The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81(9):1159-71. DOI: 10.4065/81.9.1159. View

20.

Schears G . Summary of product trials for 10, 164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs. 2006; 29(4):225-31. DOI: 10.1097/00129804-200607000-00009. View